Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone
about
Treatment of nongout joint deposition diseases: an updateInvestigating the Robustness and Diagnostic Potential of Extracellular Matrix Remodelling Biomarkers in Alkaptonuria.The Pigment in Alkaptonuria Relationship to Melanin and Other Coloured Substances: A Review of Metabolism, Composition and Chemical AnalysisNitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.Relationship Between Serum Concentrations of Nitisinone and Its Effect on Homogentisic Acid and Tyrosine in Patients with AlkaptonuriaOchronotic arthropathy as a paradigm of metabolically induced degenerative joint disease. A case-based review.Alkaptonuria.Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria.Acute fatal metabolic complications in alkaptonuria.Osteoarticular cells tolerate short-term exposure to nitisinone-implications in alkaptonuria.Cartilage biomarkers in the osteoarthropathy of alkaptonuria reveal low turnover and accelerated ageing.Analysis of Melanin-like Pigment Synthesized from Homogentisic Acid, with or without Tyrosine, and Its Implications in Alkaptonuria.Fatal oxidative haemolysis and methaemoglobinaemia in a patient with alkaptonuria and acute kidney injury.Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria.Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry.Alkaptonuria Severity Score Index Revisited: Analysing the AKUSSI and Its Subcomponent Features.On fragmenting, densely mineralised acellular protrusions into articular cartilage and their possible role in osteoarthritis
P2860
Q26852957-FA82E901-C881-4EF6-BFA7-EB8B6CD65282Q36090540-0E14F5AC-1DAD-4525-9F37-4FBE7D34C2B3Q36090565-B48826D6-431A-46B5-8F98-B7932D25FAD6Q36090570-5FC7D711-F0DB-4D1B-8C89-5B172BF20D31Q36090577-1F35AC88-58C1-4B87-BA38-ADBA0FEF332DQ38197545-248CBB91-A09F-450B-9AE6-3CD557DB8FD4Q38227178-80C8A038-E751-4911-8799-AC1F9BBCEBDDQ38414587-BD9FC206-9D11-46C6-ACBA-E5395C8D5241Q38644004-1AA3A482-91C0-4008-965E-AEA0EDB5C0ECQ38869592-7EC22034-8324-4BDB-87D7-722B09EE19F5Q39061550-4040C247-01FE-49D6-BFE3-F24DF0CC7EA2Q39109190-568A6AC3-28E3-41D8-B16D-EBC60C9E2420Q43123162-3607D854-214A-4E1C-8560-AC3C3AAD300CQ47753281-8901D573-F6A7-4093-9379-D48EE4B3C34EQ50850348-9F8CF103-23E2-4D71-92A9-A19B3AA4535DQ52588914-CAF4DBFA-E6B3-4B2E-BB84-8976E0EF40ECQ57183204-7A50F3E6-7DFA-4C03-87E1-EC343FBE6A39
P2860
Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ochronotic osteoarthropathy in ...... d its inhibition by nitisinone
@ast
Ochronotic osteoarthropathy in ...... d its inhibition by nitisinone
@en
Ochronotic osteoarthropathy in ...... d its inhibition by nitisinone
@nl
type
label
Ochronotic osteoarthropathy in ...... d its inhibition by nitisinone
@ast
Ochronotic osteoarthropathy in ...... d its inhibition by nitisinone
@en
Ochronotic osteoarthropathy in ...... d its inhibition by nitisinone
@nl
prefLabel
Ochronotic osteoarthropathy in ...... d its inhibition by nitisinone
@ast
Ochronotic osteoarthropathy in ...... d its inhibition by nitisinone
@en
Ochronotic osteoarthropathy in ...... d its inhibition by nitisinone
@nl
P2093
P2860
P1476
Ochronotic osteoarthropathy in ...... d its inhibition by nitisinone
@en
P2093
Andrew J Preston
Brenda Wlodarski
Craig M Keenan
Hazel Sutherland
James A Gallagher
Jonathan C Jarvis
Lakshminarayan R Ranganath
Peter J Wilson
P2860
P304
P356
10.1136/ANNRHEUMDIS-2012-202878
P407
P577
2013-03-19T00:00:00Z